abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Resposta da empresa

20 Set 2021

Response from Third Rock Ventures to Risky Business report

“As a Venture Capital firm that does not invest in technology and, instead seeks to translate scientific discoveries into breakthrough medicines, I do not believe that your briefing applies to the type of companies that we seek to build -- sustainable, innovative companies that can transform the lives of patients. More information about Third Rock Ventures may be found at www.thirdrockventures.com”

Linha do tempo